OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
1 pistes • 0 écoutes • 0 favoris
OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
omonioboli
0:0010:58
Knowledge
Épisodes
1
OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
omonioboli